相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
14-3-3σ regulation by p53 mediates a chemotherapy response to 5-fluorouracil in MCF-7 breast cancer cells via Akt inactivation
Guopei Zheng et al.
FEBS LETTERS (2012)
Smad4-Mediated Signaling Inhibits Intestinal Neoplasia by Inhibiting Expression of β-Catenin
Tanner J. Freeman et al.
GASTROENTEROLOGY (2012)
Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways
Qiang Chen et al.
HEPATOLOGY (2012)
Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer
Arnaud D. Roth et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Smad4 Inactivation Promotes Malignancy and Drug Resistance of Colon Cancer
Panagiotis Papageorgis et al.
CANCER RESEARCH (2011)
Prognostic Value of Reduced SMAD4 Expression in Patients With Metastatic Colorectal Cancer Under Oxaliplatin-Containing Chemotherapy: A Translational Study of the AIO Colorectal Study Group
Alexander Baraniskin et al.
CLINICAL COLORECTAL CANCER (2011)
Smad4 May Help to Identify a Subset of Colorectal Cancer Patients with Early Recurrence after Curative Therapy
Byung Kyu Ahn et al.
HEPATO-GASTROENTEROLOGY (2011)
Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells
S. Samuel et al.
ONCOGENE (2011)
LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells
Jung-Young Shin et al.
BMC CANCER (2010)
Antimetastatic Role of Smad4 Signaling in Colorectal Cancer
Bixiang Zhang et al.
GASTROENTEROLOGY (2010)
A metastatic colon cancer model using nonoperative transanal rectal injection
Melissa Donigan et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2010)
Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma
T. Noda et al.
BRITISH JOURNAL OF CANCER (2009)
Targeting transforming growth factor-β signaling in liver metastasis of colon cancer
Bixiang Zhang et al.
CANCER LETTERS (2009)
Effective Treatment of Advanced Colorectal Cancer by Rapamycin and 5-FU/Oxaliplatin Monitored by TIMP-1
Markus Wagner et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling
I. Ischenko et al.
ONCOGENE (2008)
被撤回的出版物: Akt Regulates Drug-Induced Cell Death through Bcl-w Downregulation (Publication with Expression of Concern. See vol. 14, 2019) (Retracted article. See vol. 17, 2022)
Michela Garofalo et al.
PLOS ONE (2008)
Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells
LL Kodach et al.
CARCINOGENESIS (2006)
Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells
H Azuma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway
YB Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
SMAD4 levels and response to 5-fluorouracil in colorectal cancer
P Alhopuro et al.
CLINICAL CANCER RESEARCH (2005)
A specific inhibitor of TGF-β receptor kinase, SB-431542, as a potent antitumor agent for human cancers
SK Halder et al.
NEOPLASIA (2005)
SMAD4 as a prognostic marker in colorectal cancer
H Alazzouzi et al.
CLINICAL CANCER RESEARCH (2005)
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
N Ferrara et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β-induced apoptosis
AR Conery et al.
NATURE CELL BIOLOGY (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells
W Jin et al.
BRITISH JOURNAL OF CANCER (2003)
HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells
C Knuefermann et al.
ONCOGENE (2003)
The protein kinase B/Akt signalling pathway in human malignancy
KM Nicholson et al.
CELLULAR SIGNALLING (2002)
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
JY Douillard et al.
LANCET (2000)
分享论文
